C4 Therapeutics IPO

C4 Therapeutics ("C4T") is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Register for Details

For more details on financing and valuation for C4 Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is C4 Therapeutics's ticker symbol?


What is C4 Therapeutics's stock price?

3.08 as of 5/26/23

Learn more about C4 Therapeutics

Forge green plus iconForge green minus icon

What is C4 Therapeutics funding to date?

C4 Therapeutics has raised $74MM.
Forge green plus iconForge green minus icon

When was C4 Therapeutics founded?

C4 Therapeutics was founded in 2016.